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RESEARCH ARTICLE
A transgenic zebrafish model for the in vivo study of the blood and
choroid plexus brain barriers using claudin 5
Lisanne Martine van Leeuwen1,2, Robert J. Evans3,4, Kin Ki Jim1, Theo Verboom1, Xiaoming Fang3,5,
Aleksandra Bojarczuk3,4, Jarema Malicki3,5, Simon Andrew Johnston3,4,*,‡ and Astrid Marijke van der Sar1,*,‡
ABSTRACT
The central nervous system (CNS) has specific barriers that protect the
brain from potential threats and tightly regulate molecular transport.
Despite the critical functions of the CNS barriers, the mechanisms
underlying their development and function are not well understood,
and there are very limited experimental models for their study. Claudin
5 is a tight junction protein required for blood brain barrier (BBB) and,
probably, choroid plexus (CP) structure and function in vertebrates.
Here, we show that the gene claudin 5a is the zebrafish orthologuewith
high fidelity expression, in the BBB and CP barriers, that demonstrates
the conservation of the BBB and CP between humans and zebrafish.
Expression of claudin 5a correlates with developmental tightening of
the BBB and is restricted to a subset of the brain vasculature clearly
delineating the BBB. We show that claudin 5a-expressing cells of the
CP are ciliated ependymal cells that drive fluid flow in the brain
ventricles. Finally, we find that CP development precedes BBB
development and that claudin 5a expression occurs simultaneously
with angiogenesis. Thus, our novel transgenic zebrafish represents an
ideal model to study CNS barrier development and function, critical in
understanding the mechanisms underlying CNS barrier function in
health and disease.
KEY WORDS: Claudin 5, Tight junction, Zebrafish, Blood brain
barrier, Choroid plexus, Transgene
INTRODUCTION
The central nervous system (CNS) is protected by three specialized
barriers that shield the vulnerable brain tissue from potential threats
and actively regulate exchange of ions and nutrients. The blood
brain barrier (BBB) is formed by endothelial cells between blood
and brain interstitial fluid and has extensive control over the
immediate microenvironment of the CNS (Abbott et al., 2006,
2010). Less studied are the blood-cerebrospinal fluid (CSF) barrier,
formed by the epithelial cell layer of the choroid plexus (CP)
between blood and ventricular CSF, and the epithelial cell layer of
the meningeal arachnoid between blood and subarachnoid CSF
(Abbott et al., 2006, 2010; Obermeier et al., 2013).
TheBBB and blood-CSF barrier tissues have tight junctions (TJs),
consisting of protein complexes that seal adjacent cells and actively
regulate barrier integrity (Greene and Campbell, 2016). TJs are
protein complexes containing occludins and claudins that provide a
physical barrier to block free paracellular diffusion of solutes and
macromolecules (Abbott et al., 2010).More than 20 different claudin
isoforms are known, of which at least four, Claudin 1, 3, 5 and 12, are
involved in establishing and regulating TJs in mammalian brain
endothelial cells (Abdelilah-Seyfried, 2010; Greene and Campbell,
2016). Of these, claudin 5 is the most strongly expressed in
mammalian brain microvessels (Zhang et al., 2012). Although this
protein was shown to be important for barrier integrity in mice, the
expression of claudin 5 is not conserved in themurine CP and is not a
definitive marker of the BBB (Nitta et al., 2003).
Links with BBB breakdown or dysfunction have been shown for
neurodegenerative processes, inflammation and infection. These
include, but are not limited to, Alzheimer’s disease (Schenk and de
Vries, 2016; Zenaro et al., 2016), multiple sclerosis (Macrez et al.,
2016; Schenk and de Vries, 2016), amyotrophic lateral sclerosis
(Garbuzova-Davis and Sanberg, 2014; Garbuzova-Davis et al.,
2012), vascular dementia (Ueno et al., 2016), autoimmune
encephalitis (Platt et al., 2017) and infectious meningoencephalitis
(Coureuil et al., 2017; Gibson and Johnston, 2015; Swanson and
McGavern, 2015). Targeting the breakdown or dysfunction of the
BBB in CNS disease has significant potential as treatment target, but
is severely hampered by a lack of experimental models and current
treatment is limited to broad spectrum immunosuppression/anti-
inflammatory treatment with, for example, glucocorticosteroids
(Obermeier et al., 2013). Furthermore, to improve drug delivery in
CNS disease, specific modulation of therapeutic delivery to the
brain with limited neurotoxicity is critical (Greene and Campbell,
2016), but there are very limited experimental models that allow the
required noninvasive imaging and mechanistic studies (Greene and
Campbell, 2016; O’Keeffe and Campbell, 2016; Zhang et al., 2010).
In vitro experimental models exist to study different aspects
of the BBB, but none of them can completely mimic the complex
interplay between BBB and other cells, such as immune cells or
pathogens. In addition, in vivo systems are often restricted by the use
of a single method, such as single molecular tracer injections or
immunohistochemistry. Moreover, real-time in vivo imaging of both
the BBB and CP is not possible in current models (Blanchette and
Daneman, 2015). Therefore, we set out to develop a new model and
demonstrate its potential in understanding the mechanistic biology
of the BBB and CP.
The zebrafish (Danio rerio) model has proven to be highly
accessible for real-time imaging especially in combination withReceived 11 October 2017; Accepted 13 December 2017
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fluorescently labelled tissues, and is therefore extensively used to
study development and many aspects of human disease (Holtzman
et al., 2016). Recently, two transgenic zebrafish lines were
developed to visualize CNS angiogenesis and BBB development
in vivo, demonstrating that these events occur simultaneously
(Umans et al., 2017). The zebrafish BBB and CP are similar to
higher vertebrates, and Claudin 5a has been suggested to play an
essential role in establishment and maintenance of these barriers
between systemic circulation and CNS (Henson et al., 2014; Jeong
et al., 2008; Xie et al., 2010). Early in development, at 14 h
postfertilization (hpf ), claudin 5a is expressed in the entire
developing zebrafish CNS (Zhang et al., 2010). However, soon
after, labelling is confined to the CP and brain vasculature (from
20 hpf and 48 hpf onwards, respectively) (Xie et al., 2010; Zhang
et al., 2010). Functional studies have shown size-dependent
exclusion of fluorescent tracers injected in the circulation from
2 days postfertilization (dpf ) onwards, indicative of the functional
maturation of the BBB shortly after TJ formation (Fleming et al.,
2013; Jeong et al., 2008; van Leeuwen et al., 2014; Xie et al., 2010).
Furthermore, Claudin 5a has been suggested to be involved in the
establishment of the neuroepithelial ventricular barrier, which is
essential for brain ventricle expansion and subsequent brain
development (Zhang et al., 2010, 2012). With the use of several
enhancer trap lines the presence of a diencephalic and
myelencephalic CP (dCP and mCP, respectively) has been
suggested to be present in zebrafish larvae early in development
(Bill and Korzh, 2014; Bill et al., 2008; García-Lecea et al., 2008;
Henson et al., 2014). Therefore, we considered Claudin 5a to be an
excellent candidate as the basis for our new in vivo model for the
BBB and CP, which adds specificity to the currently existing model
systems.
In this study, we have identified claudin 5a as the zebrafish
gene equivalent to human claudin 5. We have generated a claudin
5a reporter transgenic with high fidelity expression in both the
BBB and CP, making time-lapse imaging of early development of
these structures possible. Using our new transgenic we
demonstrate that the CP forms prior to expression of claudin 5a
in brain blood vessels and validate our model by showing that
once the BBB is established claudin 5a expression coincides with
new BBB vessel formation. In addition, Claudin 5a expressing
cells in the CP are ciliated ependymal cells that drive fluid flow
early in development.
RESULTS
Zebrafish claudin 5a is the human claudin 5 orthologue
In order to identify the zebrafish (Dr) orthologue of human (Hs)
protein claudin 5 (CLDN5 gene) we used a BLASTP search of the
zebrafish genome (GRCz10) using the protein sequence of Hs
claudin 5. Two zebrafish proteins, Claudin 5a and Claudin 5b, were
identified as being most similar by protein sequence (56.9% and
54.8% identical, respectively; Fig. 1A). Alignment of the zebrafish
protein sequences to the Hs sequence could not identify which of
these two proteins is the orthologue. Examination of the genomic
region and closer gene relatives of claudin 5a and 5b clearly showed
that claudin 5a shared synteny with Hs CLDN5 and that claudin 5b
was only present in ray-finned fish (Fig. 1B,C; data not shown). In
addition, examination of zebrafish expression patterns (Thisse et al.,
2004) showed that claudin 5a was expressed in the CNS ventricle
region while claudin 5b had a cardiovascular patterning. Together,
we took this as sufficient evidence that claudin 5a was the correct
target gene. Using BAC recombineering (Abe et al., 2011) we
inserted enhanced green fluorescent protein (EGFP) at the
translation start site of the claudin 5a gene with ∼200 Kb of
flanking sequence to maximise fidelity of EGFP expression to
endogenous claudin 5a (Fig. S1).
Claudin 5a is expressed in the CP of zebrafish at 1 dpf
To study the developmental expression of claudin 5a in
TgBAC(cldn5a:EGFP)vum1 larvae and correlate this to previous
performed immunohistochemical analysis (Xie et al., 2010; Zhang
et al., 2012), we performed noninvasive imaging of the brain region of
larvae daily between 1 and 9 dpf and imaging of adult zebrafish at
1.5 years (Fig. 2). As early as 24 hpf, GFPexpressionwas observed in
the area of the mCP and dCP (Fig. 2B, arrows). ThemCP consisted of
a large sheet of cells covering the roof of the hindbrain ventricle early
in development (Fig. 2B,C) that developed into a compact cluster
located in the midline of the larval head at 3 dpf (Fig. 2D). In addition
to expression in both CPs, labelling in brain parenchyma, presumably
colocalizing with vasculature, and spinal cord was observed from
3 dpf onwards (Fig. 2D, arrow). Between 3 and 5 dpf, claudin 5a
expression rapidly expanded in the entire parenchyma (Fig. 2F).
Interestingly, strong labelling in the midline of the larval head was
observed (Fig. 2B, open arrow). This labelling appeared at the same
time in both CPs, connected these structures, and was sustained
through development (Fig. 2J,J′). In addition to Claudin 5a:GFP
expression during development and maturation of the BBB and CP,
expression was maintained in the BBB of adult fish at 1.5 years
(Fig. 2K-M). Unfortunately, both CPs were difficult to access in
whole adult brain, thus CP labelling in adults could not be confirmed.
Although Claudin 5a specifically labels CNS barriers in zebrafish,
transient expression was observed in the caudal hematopoietic tissue
(CHT), the tip of the tail and the heart region (Fig. S2). This
expression was only present during early development and
disappeared in later larval stages (data not shown). Collectively, our
TgBAC(cldn5a:EGFP)vum1 larvae and adult zebrafish showed
specific expression in brain vasculature and, in larvae, in both CPs
labelling the BBB and blood-CSF barrier, respectively.
Claudin 5a expression in brain vasculature rapidly expands
between 3 dpf and 4 dpf
To study if Claudin 5a can be found in tight junctions of brain
vasculature and therefore represents the BBB, we injected our
construct in the vascular specific reporter line Tg(kdrl:mCherry)is5
(Jin et al., 2005) to generate a double transgenic line, Tg(kdrl:
mCherry)is5;TgBAC(cldn5a:EGFP)vum2. Using the previously
described detailed anatomical description of vasculature
development (Isogai et al., 2001), we observed that expression of
claudin 5a first appeared in themesencephalic vein (MsV) andmiddle
cerebral vein (MCeV) at 3 dpf (Fig. 3A,B). Subsequent expansion of
claudin 5a expression between 3 and 4 dpf occurred in large vessels
first (Fig. 3C,D). At 5 dpf, nearly all vessels, veins and arteries, show
green fluorescence indicating that claudin 5a is expressed in virtually
all the vessels in the zebrafish brain (Fig. 3E,F). Intriguingly, a certain
number of specific areas never showed claudin 5a expression (15 of
16 larvae, three biological independent experiments, Fig. 3G): the
primordial midbrain channels (PMBC), choroidal vascular plexus
(CVP) (Fig. 3G, arrows), anterior cerebral vein frontally located
(ACeV) (Fig. 3I-K), and at the location of the midbrain the dorsal
midline junction (DMJ) and dorsal longitudinal vein (DLV)
(Fig. 3L-N). In addition, the strong labelling in the midline of the
larval head did not colocalize with blood vessels (Fig. 3H, open
arrow). The Claudin 5a-deficient regions were sustained through
development until at least 9 dpf and were present independent of
zebrafish background [WT, Casper or Tg(kdrl:mCherry)].
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Claudin 5a expression occurs prior to new BBB vessel
formation
As stated above, we had identified that Claudin 5awas first present in
the larger vessels. Development and expansion of brain vasculature
continues after 4 dpf, when claudin 5a expression is established. The
timing of tight junction protein expression in the BBB has been
unstudied for long due to the absence of a suitable in vivo model
(Haddad-Tóvolli et al., 2017). Recently, two transgenic zebrafish
lines were developed that showed that tight junction protein
expression occur together with CNS angiogenesis (Umans et al.,
Fig. 1. Zebrafish Claudin 5a is the homologue of
human claudin 5. (A) Protein sequence alignment
of human (Hs; Homo sapiens) claudin 5, zebrafish
(Dr; Danio rerio) Claudin 5a and Claudin 5b using
Clustal Omega. (B,C) Syntenic analysis of
claudin 5a (B) and claudin 5b (C) genes. (B) Green:
Syntenic genes in the claudin 5a locus across
Latimeria chalumnae (Lc), Oryzias latipes (Ol),
Danio rerio (Dr), Xenopus laevis (Xl) and Homo
sapiens (Hs). Purple: Syntenic genes in the
claudin 5a locus across Osteichthyes (Lc, Ol, Dr).
Blue: Unique gene present in the claudin 5a locus of
Xenopus laevis. Open bar, 250 Kb. (C)Claudin 5b is
only present in Actinopterygii (ray-finned fish), here
represented by Oryzias latipes (Ol) and Danio rerio
(Dr), which show conserved synteny. Syntenic
genes in the claudin 5b locus across Actinopterygii.
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Fig. 2. Developmental expression of claudin 5a. (A) Lateral view of a Casper zebrafish larva at 1 dpf and 7 dpf. Boxed areas represent the brain regions
of which confocal images are shown in B-J. (B-J) Z-stacks of dorsal view of larval head to visualize development of GFP expression from 1 to 9 dpf. GFP
expression can be found in the dCP and mCP from 1 dpf onwards (B, closed arrow). In addition, labelling is observed in the midline connecting the dCP
and mCP (B, open arrow, J’). From 3 dpf onwards, labelling in brain parenchyma is observed (D, open arrow). (K) Diffuse GFP expression in brain region of adult
zebrafish, 1.5 years, with corresponding brightfield image. The boxed area in K and its inset is enlarged in M and L, respectively. (L) Brightfield image of blood
vessel in adult brain, colocalizing with (M) Claudin 5a:GFP expression. Scale bars: 100 μm in B-J; 1 mm in K; 200 μm in L,M.
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2017). Therefore, we aimed to test and validate our model in this
respect. Using long time-lapse imaging over 12 h, starting at 96 hpf
(3 dpf), in our Tg(kdrl:mCherry)is5;TgBAC(cldn5a:EGFP)vum2
double transgenic, we were able to identify sprouting vessels and
follow their growth and correlation with claudin 5a expression.
Careful analysis of sprouting vessels revealed that, in every case,
claudin 5a expression was observed simultaneously with the
initiation of a new vessel (Fig. 4; Movies 1 and 2). This indicates
that components of tight junctions were expressed from the initiation
of BBB angiogenesis and demonstrates the essential nature of early
expression of these junctions in BBB development.
Zebrafish larvae possess two separate blood-CP barriers
that exhibit collective cell migration
To determine the position of the claudin 5a-expressing cells being a
major component of the blood-CP barrier, its localisation in respect
to the vasculature was analysed in more detail in the double
transgenic line Tg(kdrl:mCherry)is5;TgBAC(cldn5a:EGFP)vum2.
Three-dimensional confocal analysis revealed that the ACeV and
prosencephalic artery (PrA) formed a vascular circuit early in
development, which overlapped with claudin 5a expression at the
location of the dCP (Fig. 5A,B). In themCP in the roof of the hindbrain
ventricle a similar pattern was seen: the DLV and both posterior
cerebral veins (PCeV) formed a vascular circuit closely related to the
cells expressing claudin 5a (Fig. 5C,D). This colocalization did
not change during the course of days (Fig. 5A-D, compare 4 dpf
with 9 dpf), with the barrier between systemic circulation and CP
established early in development. Detailed analysis of the cell
dynamics of both CPs identified that the main morphological
transformations occur between 1 dpf and 3 dpf (Fig. 5E-I), as
proposed by a previous study performed in a CP enhancer trap
zebrafish transgenic (Bill et al., 2008; García-Lecea et al., 2008). We
performed cell-tracking experiments on both CPs, to demonstrate time-
lapse possibilities in this model and reveal mechanisms involved in CP
formation. Cell tracking demonstrated that both structures formed via
cell migration rather than cell division (Fig. 5E,F; Movies 3 and 4),
where claudin 5a expressing cells formed a single layer of closely
connected cells that were localized in the roof of both ventricles, before
and after movement to the midline (Fig. 5G-I).
Claudin 5a expression delineates the structured epithelial
sheet of the CP
The CP is a contiguous epithelial sheet with tight junctions (Lun
et al., 2015). To further validate our transgenic, and demonstrate its
utility in studying the fine structure of the CP, we labelled
endogenous protein via immunohistochemistry with a monoclonal
Fig. 3. Development ofClaudin 5a expression in brain vasculature. (A,B) Dorsal view of head of Tg(kdrl:mCherry)is5;TgBAC(cldn5a:EGFP)vum2 larva at 3 dpf.
Merge of both channels is shown in A, single green fluorescent expression is shown in B. Claudin 5a is first expressed in the mesencephalic vein (MsV) and
middle cerebral vein (MCeV). (C-F) Expansion of claudin 5a expression over time, with almost all blood vessels expressing claudin 5a at 5 dpf (E-F): dorsal
view (C,D), dorsal/lateral view (E,F). (G,H) Dorsal view of head of Tg(kdrl:mCherry)is5;TgBAC(cldn5a:EGFP)vum2 larva at 9 dpf. The boxed areas are shown
enlarged in I-K and L-N. Open arrow shows the strong expression of claudin 5a in the midline in the absence of a colocalizing blood vessel (H). Specific spots that
never express claudin 5a are the primordial midbrain channels (PMBC) and choroidal vascular plexus (CVP) (G), anterior cerebral vein (ACeV) (I), and dorsal
midline junction (DMJ) and dorsal longitudinal vein (DLV) (L). Scale bars: 100 μm in A,C,E,G; 25 μm in I,L.
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antibody to mammalian claudin 5 for comparison. Antibody
labelling identified a tight network of epithelial cells with claudin
5 localized to the cell margins in both the mCP and dCP structures
(Fig. 6A-E). This correlated with cldn5a:EGFP expression in the
TgBAC(cldn5a:EGFP)vum1 and light-sheet imaging was able to
resolve the same network of cells and cell junctions, even though the
subcellular localizations are not exactly the same (Fig. 6F-J).
Differences in localisation of EGFP expression were found, due to
accumulation of expressed protein in the cytoplasm of cells in the
TgBAC(cldn5a:EGFP)vum1 transgene and localisation of antibody
labelling at the cell membranes.
The cldn5a:EGFP-expressing sheet contains ciliated
ependymal cells that drive cerebral spinal fluid flow
The cells of the CP are a specialized type of ependymal cells, which
line the brain ventricles. To confirm the identity of our cldn5a:
Fig. 4. Initiation of claudin 5a expression coincideswith blood vessel formation. (A,B) Still images of two time lapses of blood vessel development in Tg(kdrl:
mCherry)is5;TgBAC(cldn5a:EGFP)vum2 larva at 96 hpf. Images were taken every 2.5 h for a period of 12.5 h on blood vessels in the optic tectum of the
midbrain. Images of single channels show blood vessel development (kdrl:mcherryCAAX) on the top row, coinciding with development of claudin 5a in themiddle
row. Merged images are shown in the bottom row. Scale bars: 20 μm. See corresponding movies of time lapses (Movies 1 and 2).
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EGFP cells we stained for glutamylated tubulin to label cilia. We
could image single cilia from cldn5a:EGFP cells in the mCP and
dCP as early as 2 dpf (Fig. 7A-D). Only monociliated cells were
found at all stages examined in the fore and hind brain (Fig. 7A-P).
We could determine the polarity of the cldn5a:EGFP cells on the
basis of the abundant labelling of glutamylated tubulin in the skin,
which revealed that cilia project into the brain ventricles (Fig. 7B,D,
F,H,J,L,N,P). CSF is under constant flow that is thought to result
from a combination of secretion of CSF from cells of the CP and the
beating of the cilia lining the brain ventricles (Kramer-Zucker et al.,
2005; Sawamoto et al., 2006). Using injection of fluorescently
labelled beads we were able to observe vigorous fluid flow in the
CSF in both the fore- and hindbrain ventricles (Movies 5 and 6).
DISCUSSION
Claudin 5 as a prominent TJ protein is a consistent feature between
the BBB and blood-CSF barrier (Bill and Korzh, 2014). Here we
have used this feature to create an in vivo model for real-time
analysis of the development, structure and function of the BBB and
CP by generating a transgenic zebrafish line that expresses EGFP
under the claudin 5a promoter. The high homology and synteny
with human, the conservation along the teleost lineage and the
previous characterisation of Claudin 5a in zebrafish makes cldn5a a
logical candidate (Abdelilah-Seyfried, 2010; Xie et al., 2010; Zhang
et al., 2012).
We show that developmental expression of cldn5a:EGFP is
restricted to, and starts in both CPs and the midline at 1 dpf, thereby
narrowing down the previously shown whole-mount in situ
hybridizations (Zhang et al., 2010). The presence of Claudin 5a at
the CPs at 1 dpf coincides with the inflation of the ventricles (Zhang
et al., 2010, 2012) and corroborates its role in this process. Claudin 5a
is crucial for tightening the neuroepithelial paracellular barrier, and
probably also important for proper formation of the CP, allowing the
production of cerebral spinal fluid (CSF) and inflation of both
Fig. 5. Blood-CP barrier. (A) Dorsal view of dCP
of Tg(kdrl:mCherry)is5;TgBAC(cldn5a:
EGFP)vum2 larva at 4 dpf, showing the close
correlation between the vasculature (red) and
claudin 5a-expressing cells (green). The ACeV
and PrA form a vascular circuit surrounding the
dCP. Transversal view with 3D model (A′) and
single Z-slice at the dotted line in A (A″) visualize
the close correlation between these structures.
(B) Dorsal view of dCP in a larva at 9 dpf, with
transversal view in a 3D model (B′) and single
Z-slice at dotted line (B″). (C) At 9 dpf, the blood-
dCP barrier is formed by the PrA. At the level of
the mCP, the PCeV and DLV form a vascular
circuit. Transversal view in C′ with a 3D model
and C″ with a single Z-slice at the level of the
dotted line in C show the close correlation
between the mCP and vasculature. (D) Dorsal
view of mCP in a larva at 9 dpf, with transversal
view in a 3D model (D′) and single Z-slice at
dotted line (D″). ACeV, anterior cerebral vein;
DLV, dorsal longitudinal vein; PCeV, posterior
cerebral vein; PrA, prosencephalic artery.
(E) First and last images of time lapse of dCP cell
migration at 48-51 dpf. Time lapse is presented
in Movie 3. (F) First and last images of time lapse
of mCP cell migration at 48-51 dpf. Time lapse is
presented inMovie 4. (G-I) Dorsal view of head of
TgBAC(cldn5a:EGFP)vum2 larvae between 1 dpf
and 3 dpf, the timeframe in which the major
morphological transformation is observed.
Transversal section is shown for every time point
in G′,H′,I′ and G″,H″,I″, corresponding to the
dotted lines depicted in G-I. This visualizes the
superficial localisation of the GFP-expressing
cells of the mCP and dCP. Scale bars: 50 μm in
A-F; 100 μm in G-I.
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ventricles. These ventricles are connected and form a system through
which continues flow of CSF is ensured (Turner et al., 2012).
Expression of claudin 5a possibly outlines the entire ventricular
system, which can be an explanation of the midline staining we
observe. Expression in the brain vasculature is only found at 3 dpf.
Within the functional highly diverse CNS, the microvasculature
is expected to consist of a heterogeneous population of brain
microvascular endothelial cells (BMECs) (Wilhelm et al., 2016). A
considerable majority of CNS microvasculature comprise
capillaries, of which the BMECs preferentially express genes
related to transport of ions and nutrients (Macdonald et al., 2010).
BMECs of venules instead show higher expression of genes
involved in inflammatory-related processes and were shown to have
a looser organisation of tight junctions as compared to capillaries.
This suggests a vessel-specific unique role in physiology and
pathophysiology (Macdonald et al., 2010). It is likely that the
majority of expression of tight junction-related genes cover all
vessel types to sustain the protective function of the BBB.
Therefore, the observation made in this study that some blood
vessel segments lack claudin 5a expression was highly surprising.
In mice, similar heterogeneous expression of claudin 5 has been
observed in the spinal cord, with highest expression in capillaries
and small venules and less expression in larger venules (Paul
et al., 2013). Induction of experimental autoimmune encephalitis
(EAE) led to loss of claudin 5 expression specifically in venules,
suggesting an important vessel specific role for claudin 5 in this
condition (Paul et al., 2013). Another plausible explanation for the
variation in Claudin 5a presence in our model is the anatomical
localisation of the blood vessels in respect to brain tissue. Blood
vessel segments lacking claudin 5a expression were all located at
the borders of the brain and in close proximity to meninges.
Therefore, it is likely that these vessels are located outside the
parenchyma and do not possess a BBB.
Development of the CNS vascular network involves complex
changes in endothelium and surrounding tissue and the timing of
BBB formation in this process is difficult to pinpoint (Malinovskaya
et al., 2016). Elaborate studies in rodents and zebrafish have shown
that CNS vascularisation during development mainly occurs
through angiogenesis derived from the perineural vascular plexus
driven by VEGF and CNS-specific Wnt/beta-catenin signalling
(Blanchette and Daneman, 2015; Hagan and Ben-Zvi, 2015;
Obermeier et al., 2013; Umans et al., 2017). Within a few days
after initiation of vessel formation, restricted properties have been
demonstrated by exclusion of fluorescent dyes from the CNS.
Remarkably, this seem to happen before astrocyte generation and
ensheathment of vessels occur, while these events have always been
considered to be essential for BBB establishment (Blanchette and
Daneman, 2015). Recently, within a transgenic zebrafish model for
Fig. 6. CP morphology. (A) Dorsal
view of the head of a 7 dpf Tg(kdrl:
mCherry)is5 larva showing blood
vessels (red) and
immunohistochemistry (IHC)
labelling of Claudin 5 (cyan). Boxed
areas are shown enlarged in B,D and
C,E, and show detailed analysis of
the collection of cells that forms the
dCP (B) and mCP (C) and is closely
connected by Claudin 5. The sheet of
cells found in the dCP and mCP of a
7 dpf TgBAC(cldn5a:EGFP)vum2
larva is similar to the phenotype in
A-E, although subcellular
localizations are not the same.
(F) Z-stack of mCP of a Tg(kdrl:
mCherry)is5;TgBAC(cldn5a:
EGFP)vum2 larva with red fluorescent
blood vessels (G) and cyan
fluorescent claudin 5a (H). Boxed
areas are shown enlarged in I and J,
showing high magnification of the
network formed by claudin 5a-
expressing cells forming the mCP.
Scale bars: 100 μm in A; 50 μm in B,
C; 10 μm in D,E; 50 μm in F-H; 10 μm
in I,J.
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BBB development, it was observed for the first time that
barriergenesis occurs simultaneously with CNS angiogenesis
(Umans et al., 2017). Moreover, expression of TJ proteins is
present at the initiation of angiogenesis in the CNS of mice with
subsequent increase of TJ functionality during embryogenesis
(Daneman et al., 2009, 2010). In the opossum, it has been
demonstrated that newly formed blood vessels possess functional
properties from their initiation (Ek et al., 2006). Our study offers a
possible mechanism for this, whereby new vessels express claudin
5a immediately to form TJs, reflecting developmental steps
observed in other models and demonstrating how our transgenic
will enable determination of TJ and BBB specification and
functionality.
The timespan between initial TJ expression and a functionally
intact BBB was for long believed to be the main reason for
differences in BBB permeability at different ages. However,
considering that these events coincide, an alternative explanation
is a prolonged permeability of the barrier between blood and CP (Ek
et al., 2006; Saunders et al., 2012). The last decade it has become
clear that the blood-CP barrier has more functions than solely
CSF production and makes significant contributions to brain
homeostasis. Junctional, enzymatic and transporter proteins have
been identified and the CP may serve as entry route for immune
cells, compounds and even pathogens (Lun et al., 2015). The blood-
CP barrier is formed by a monolayer of cuboidal epithelial cells, i.e.
ependymal cells, which surround stromal tissue and capillaries, and
are joined together by tight junctions (Lun et al., 2015). Studies with
enhancer trap lines were the first to describe the two CPs in zebrafish
and suggested that at least four different cell lineages develop into
stromal, epithelial, endothelial and astroglial components (Bill and
Korzh, 2014). The previously described enhancer trap line shows a
broad expression profile, of an unidentified gene, in the region of the
CP (Bill et al., 2008; García-Lecea et al., 2008). In precision, our
transgenic line corroborates and extends those findings and shows
cells originating from the roofplate express claudin 5a and develop
into ciliated ependymal cells.
The treatment of CNS disease is severely impeded by an inability
to modulate the entry and exit of therapeutic compounds. Therefore,
an improved understanding of the biology of the BBB and blood-CP
barrier is of essential importance to improve treatment. Claudin 5 is
a tempting target for manipulation, since many hydrophilic drugs
prefer to cross the BBB via the paracellular pathway (Greene and
Campbell, 2016; Saunders et al., 2013). However, to reduce
potential dangerous consequences extensive studies in in vivo
models are needed before this therapy can be applied in the clinical
setting (O’Keeffe and Campbell, 2016). Promising results were
achieved in a mice model for cerebral oedema, a major cause for
morbidity and mortality in a wide variety of conditions, such as
severe traumatic brain injury, neurological cancers and brain
infections. Strategies to prevent or treat this condition are limited,
but transient modulation of claudin-5 with RNAi led to reduced
brain swelling and a better outcome (Campbell et al., 2012). In
zebrafish, a mutated fragment of clostridium perfringens
enterotoxin has been shown to specifically target and modulate
claudin 5, inducing transient paracellular permeability of the BBB
(Liao et al., 2016). As zebrafish have also proven to be an
outstanding model for new compound screens (North et al., 2007;
Robertson et al., 2014), analysis of pharmacodynamics of the
compound entry into the CNS is now eminently feasible.
MATERIALS AND METHODS
Identification of zebrafish Claudin 5 and BAC recombineering
Human (genome build GRCh38.p7) CLDN5 protein sequence
(NP_003268.2) was used in a BLAST search of the zebrafish protein
database (genome build GRCz10). Zebrafish Claudin 5a and Claudin 5b
proteins were identified and aligned with human claudin 5 using Clustal
Omega. Using synteny and expression pattern zebrafish claudin 5a was
confirmed as the homologue of humanCLDN5. A search of zebrafish genome
BACs identified BAC 187M8 from the CHORI211 library (Robert Geisler
and Pieter de Jong, Children’s Hospital Oakland Research Institute) as
suitable for generation of a fluorescent reporter line due to significant flanking
sequence up- and downstream of the claudin 5a gene. Primers were designed
with a forward primer with 50 bp upstream and including the ATG codon of
claudin 5a and 24 bp of the targeting vector containing EGFP and a
Kanamycin resistance cassette (Dee et al., 2016). The reverse primer
contained the reverse complement sequence of the 50 bp downstream of
the ATG codon of claudin 5a and the reverse complement of the end of
Fig. 7. cldn5a:EGFP-labelled cells in the
CP are ciliated throughout development.
Images of cilia visualized by staining with
anti-glutamylated tubulin antibody (red) and
cldn5a:EGFP-positive cells (green).
(A,E,I,M) Confocal images of the dorsal view
of the dCP in 2, 3, 5, 9 dpf as indicated.
(B,F,J,N) Side views of the dCP at the same
stages. Cilia project from GFP-positive cells.
(C,G,K,O) Dorsal views of the mCPat 2, 3, 5,
9 dpf, respectively. (D,H,L,P) Side views of
the mCP. Cilia projected from the GFP-
labelledmCP cells. For A,C,E,G,I,K,M,O, the
red channel is shown separately to the right.
Arrows indicate cilia. In dorsal view panels,
anterior is down. In all side view panels,
dorsal is up. Scale bars: 15 µm. Scale bar in
P applies to all side view images (B,D,F,H,J,
L,N,P). Scale bar in O applies to all dorsal
views of the mCP (C,G,K,O).
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the cassette sequence. Forward primer: AACTTCTAAACTCCTTTTAGT-
ACCATCAGGAGTGGGAAAAGAAAGCGATGGTGAGCAAGGGCG-
AGGAGCTGTTC; reverse primer: GTCCCGCAGACGCACAGGATC-
AGACCCAGGAGCTCCAAAGCCGCGGAGGCGATATCTGCAGAA-
TTCGCCCTTGA. Tol2 homology arms (Fig. S1) were added as described
previously (Gray et al., 2011). Two nanolitres of recombineered BAC DNA
at a concentration of 50 ng/µl combined with itol2 mRNA (Abe et al., 2011)
at 30 ng/µl. were injected to perform transgenesis.
Zebrafish
Maintenance of adult zebrafish took place at 26°C in aerated 5 litre tanks, in
a 10:14 h light:dark cycle. Eggs were collected within the first hour
postfertilization and injected at the 1-4 cellular stage. Injection was
performed as described previously (Benard et al., 2012). Initial transgenesis
was performed on: (1) WT zebrafish (van der Sar et al., 2004); (2) casper
zebrafish, transparent because these zebrafish lack pigment (White et al.,
2008); and (3) Tg(kdrl:mCherry), with red fluorescent endothelial cells (Jin
et al., 2005). All procedures involving zebrafish embryos and larvae and
adult were performed in compliance with local animal welfare laws under
Dier Ethische Commissie (DEC) protocol (MMI 12-01).
Transgenesis
At 4 dpf, larvae injected with the construct were analysed for transgenic
expression with a Leica MZ16FA fluorescence microscope. F0-embryos
expressing EGFP in the brain region were selected and grown until
reproducing age. Subsequent selection took place and F1 larvae with good
expression were used for egg production. F2 larvae were used for further
analysis and experiments described here. Stable germline transgenics
TgBAC(cldn5a:eGFP)vum1 and Tg(kdrl:mCherry)is5;TgBAC(cldn5a:eGFP)vum2
were generated and used for the experiments.
Whole-mount zebrafish larval staining
Visualisation of Claudin 5 expression in the BBB of zebrafish larvae
was done by performing whole-mount immunohistochemical staining
on fixed larvae. For this, larvae were euthanized at indicated time
points with tricaine (E10521, Sigma-Aldrich) and fixed in 4% (V/V)
paraformaldehyde/PBS (100122, Electron Microscopy Sciences, Hatfield,
USA) at 4°C overnight or at room temperature (RT) for 4 h in microfuge
tubes. Fixed larvae were dehydrated and stored in 100% methanol at −20°
C until anti-claudin 5 staining was performed. In short, larvae were
rehydrated, rinsed with 1% PBTx (PBS+1% Triton X-100), permeated in
0.24% trypsin in PBS and blocked for 3 h in block buffer [10% normal
goat serum (NGS) in 1% PBTx (V/V)] Incubation with the primary
antibody was performed overnight at RT [mouse anti-Claudin 5 (4C3C2),
187364, Invitrogen; 1:500 dilution] in antibody buffer [PBTx containing
1% (V/V) NGS and 1% (W/V) BSA]. After washing again with PBTx
and incubation for 1 h in block buffer, embryos were incubated in the
secondary antibody (goat anti-mouse Alexa-647, A21070, Invitrogen;
1:400 dilution), overnight at 4°C. Embryos were then washed with PBTx
5 times, 10 min each.
For staining with anti-glutamylated tubulin, washing with PBST (PBS
+0.1% Tween) was applied after fixation. Samples were transferred to 1%
Triton X-100 in PBST and incubated at RT for 1-5 days to permeabilize.
Larvae were placed in the blocking buffer [0.5% (V/V) Triton, 2% (V/V)
normal goat serum in PBST] at room temperature for 2 h. Subsequently, the
blocking buffer was removed and replaced with blocking buffer containing
the primary antibody [anti-glutamylated tubulin (GT335) mouse IgG,
AdipoGen Life Sciences, Liestal, Switzerland; 1:650 dilution]. Specimens
were incubated in this solution at 4°C overnight. Larvaewere then washed in
PBST three times, 30 min each, on a rotator and incubated in secondary
antibody (goat anti-mouse Alexa-568, Invitrogen; 1:500 dilution) in the
blocking buffer for 4 h at room temperature. Embryos were washed with
PBST three times, 10 min each.
Microscopy
For imaging, embryos were mounted in a drop of 1.5% low melting agarose
placed on the surface of 1% agarose gel layer in a 35-mm petri dish [A9414,
Sigma-Aldrich (now Merck, Darmstadt, Germany)] or embedded in 1% low
melting-point agarose [12841221-01, Boehringer Mannheim (Roche
Diagnostics), Basel, Switzerland] dissolved in egg water (60 μg/ml instant
ocean see salts) in an eight-well microscopy μ-slide (http://www.ibidi.com).
Analysis was performed with a confocal laser scanning microscope (confocal,
Leica TCS SP8 X; microscope, Leica DMI 6000). LAS software and ImageJ
software were used to generate 3D models, adjust brightness and contrast and
create overlays. Adult zebrafish were euthanized with tricaine (E10521, Sigma-
Aldrich) and directly embedded in 2% low melting-point agarose (12841221-
01, Boehringer Mannheim) dissolved in egg water (60 μg/ml instant ocean see
salts) with the dorsal side up. The cranial roofwas removed to expose the brain.
Analysis was performed with a Leica MZ16FA Fluorescence Stereo
Microscope. Brightfield and fluorescence images were generated with a
Leica DFC420C camera using LAS software.
Time-lapse imaging
Time-lapse imaging was performed with light-sheet fluorescence
microscopy on a Zeiss Z1 with Z.1 detection optics 20×1.0 NA water
immersion objective lens. Zebrafish larvae were mounted in 0.8% low
melting point agarose (A9414, Sigma-Aldrich) in E3 containing 0.168 mg/ml
tricaine (E10521, Sigma-Aldrich). Z-stacks were captured every 30 min
over 12.5 h or 16 h. Maximum intensity projections were generated in Zeiss
Zen software. Image processing (cropping, generation of merged
images, and linear adjustment of pixel levels) was performed in Fiji
ImageJ 2.0.0. Tracking was performed using the Manual Tracking plugin
included in Fiji.
Bead flow assay
Nacre fish were injectedwith 4×103 1.75 mmbeads (fluoresbrite carboxylate;
Polysciences Inc., Warrington, USA) into the hindbrain ventricle 2 dpf. Bead
flow was imaged 24 h postinfection in the hind- and forebrain ventricles with
a Nikon Ti-Ewith a CFI PlanApochromat λ 20×, 0.75NA objective lens, and
using Intensilight fluorescent illumination with ET/sputtered series
fluorescent filters (Chroma, Bellow Falls, VT, USA). Images were captured
with Neo sCMOS, 2560×2160 Format, 16.6 mm×14.0 mm Sensor Size,
6.5 μm pixel size camera (Andor, Belfast, UK) and NIS-Elements (Nikon,
Richmond, UK). Images were processed (cropping, contrast enhancement)
using NIS-Elements.
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